ArticleHeliyon2024

Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis.

Haolong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.